Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink.
暂无分享,去创建一个
Mark Lunt | Rosa Parisi | M. Rutter | D. Symmons | C. Griffiths | H. Young | M. Lunt | C. Griffiths | D. Ashcroft | D. Symmons | R. Parisi | Darren M. Ashcroft | Martin K. Rutter | Helen S. Young | Deborah P.M. Symmons | Christopher E.M. Griffiths
[1] Andrea B Troxel,et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. , 2010, European heart journal.
[2] P. Chowienczyk,et al. Chronic Inflammatory Disorders and Risk of Type 2 Diabetes Mellitus, Coronary Heart Disease, and Stroke: A Population-Based Cohort Study , 2014, Circulation.
[3] A. Troxel,et al. The risk of stroke in patients with psoriasis. , 2009, The Journal of investigative dermatology.
[4] L. Skov,et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study , 2011, Journal of Internal Medicine.
[5] R. Warren,et al. Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis. , 2013, The Journal of investigative dermatology.
[6] M. Lai,et al. Increased risk of diabetes mellitus in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. , 2014, Journal of the American Academy of Dermatology.
[7] Douglas G Altman,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. , 2014, International journal of surgery.
[8] M. Bala,et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. , 2006, The Journal of rheumatology.
[9] F. Granath,et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients , 2003, European Journal of Epidemiology.
[10] O. Franco,et al. Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study. , 2013, The Journal of investigative dermatology.
[11] P. Kiely,et al. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. , 2010, Rheumatology.
[12] M. Gulliford,et al. Selection of Medical Diagnostic Codes for Analysis of Electronic Patient Records. Application to Stroke in a Primary Care Database , 2009, PloS one.
[13] H Jick,et al. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. , 1991, BMJ.
[14] Daniel B. Shin,et al. Risk of myocardial infarction in patients with psoriasis. , 2006, JAMA.
[15] J. Manson,et al. Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study , 2012, The British journal of dermatology.
[16] L. Skov,et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. , 2011, European heart journal.
[17] David J Margolis,et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. , 2004, The journal of investigative dermatology. Symposium proceedings.
[18] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.
[19] D. Margolis,et al. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. , 2003, Archives of dermatology.
[20] Herng‐Ching Lin,et al. Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan. , 2011, Journal of the American Academy of Dermatology.
[21] W. Boehncke,et al. The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity , 2011, Experimental dermatology.
[22] D. Reeves,et al. ClinicalCodes: An Online Clinical Codes Repository to Improve the Validity and Reproducibility of Research Using Electronic Medical Records , 2014, PloS one.
[23] Philip J. B. Brown,et al. Application of Information Technology: Updating the Read Codes: User-interactive Maintenance of a Dynamic Clinical Vocabulary , 1997, J. Am. Medical Informatics Assoc..
[24] Daniel B. Shin,et al. Prevalence of cardiovascular risk factors in patients with psoriasis. , 2022, Central European journal of public health.
[25] Hyon K. Choi,et al. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. , 2007, Archives of internal medicine.
[26] Rosa Parisi,et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. , 2013, The Journal of investigative dermatology.
[27] R. Herings,et al. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. , 2010, The Journal of investigative dermatology.
[28] D. Margolis,et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study , 2014, Annals of the rheumatic diseases.
[29] E. Samarasekera,et al. Psoriasis: guidance on assessment and referral. , 2014, Clinical medicine (London).
[30] S. Jick,et al. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case–control analysis , 2009, The British journal of dermatology.
[31] L. Naldi,et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. , 2005, The Journal of investigative dermatology.
[32] T. Nijsten,et al. Complexity of the association between psoriasis and comorbidities. , 2009, The Journal of investigative dermatology.
[33] H. John,et al. Inflammatory arthritis as a novel risk factor for cardiovascular disease. , 2012, European journal of internal medicine.
[34] S. Gabriel,et al. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE , 2011, Nature Reviews Rheumatology.
[35] P. Rose,et al. Validity of diagnostic coding within the General Practice Research Database: a systematic review. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.
[36] S. Jick,et al. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis , 2008, The British journal of dermatology.
[37] L. Smeeth,et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review , 2010, British journal of clinical pharmacology.
[38] C. Herzog,et al. Psoriasis: a possible risk factor for development of coronary artery calcification , 2007, The British journal of dermatology.
[39] R. Stern,et al. Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk. , 2011, The Journal of investigative dermatology.
[40] D M Reboussin,et al. Psoriasis causes as much disability as other major medical diseases. , 1999, Journal of the American Academy of Dermatology.
[41] David J Margolis,et al. Determinants of quality of life in patients with psoriasis: a study from the US population. , 2004, Journal of the American Academy of Dermatology.
[42] C. Griffiths,et al. Pathogenesis and clinical features of psoriasis , 2007, The Lancet.